Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
At close: Mar 5, 2026

Genix Pharmaceuticals Company Description

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada.

The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops.

It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism.

The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019.

Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.

Genix Pharmaceuticals Corporation
Genix Pharmaceuticals logo
Country Canada
Founded 1993
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 4,000
CEO Sina Pirooz

Contact Details

Address:
1055 West Hastings Street
Vancouver, BC V6E 2E9
Canada
Phone 604-609-6198
Website genixpharm.com

Stock Details

Ticker Symbol GENX
Exchange TSX Venture Exchange
Fiscal Year November - October
Reporting Currency CAD
ISIN Number CA37232A1093
SIC Code 2834

Key Executives

Name Position
Sina Salehi Pirooz Chief Executive Officer and Director
Mahmoud S. Aziz Chairman of the Board and President
Wayne Kent Lee CA, CPA Chief Financial Officer
Kevin James Bottomley Director of Corporate Development and Independent Director